Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Financial Flexibility Index
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-12.90 Million (operating CF CN¥-19.96 Million minus capex CN¥7.06 Million) represents 0% of total liabilities (CN¥335.43 Million). Check 600671 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 600671 cash generation efficiency.
Annual Financial Flexibility Index for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. Explore 600671 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥42.97 Million | CN¥11.79 Million | CN¥348.04 Million | ▲ +373.0% |
| 2024 | -0.05x | CN¥-16.12 Million | CN¥-36.67 Million | CN¥356.44 Million | ▼ -14.5% |
| 2023 | -0.04x | CN¥-11.47 Million | CN¥-20.43 Million | CN¥290.34 Million | ▲ +26.4% |
| 2022 | -0.05x | CN¥-15.85 Million | CN¥-19.37 Million | CN¥295.36 Million | ▲ +16.4% |
| 2021 | -0.06x | CN¥-21.71 Million | CN¥-26.42 Million | CN¥338.09 Million | ▼ -751.8% |
| 2020 | 0.01x | CN¥3.44 Million | CN¥-8.40 Million | CN¥349.18 Million | ▼ -98.5% |
| 2019 | 0.65x | CN¥255.78 Million | CN¥161.13 Million | CN¥393.60 Million | ▲ +139.7% |
| 2018 | 0.27x | CN¥108.17 Million | CN¥70.71 Million | CN¥398.99 Million | ▲ +10.7% |
| 2017 | 0.24x | CN¥86.77 Million | CN¥24.52 Million | CN¥354.18 Million | ▲ +119.2% |
| 2016 | 0.11x | CN¥26.82 Million | CN¥1.61 Million | CN¥240.01 Million | ▲ +113.0% |
| 2015 | 0.05x | CN¥11.42 Million | CN¥-1.47 Million | CN¥217.63 Million | ▼ -66.2% |
| 2014 | 0.16x | CN¥31.11 Million | CN¥653.79K | CN¥200.40 Million | ▲ +48.9% |
| 2013 | 0.10x | CN¥23.98 Million | CN¥12.37 Million | CN¥230.01 Million | ▲ +210.1% |
| 2012 | -0.09x | CN¥-19.24 Million | CN¥-19.82 Million | CN¥203.17 Million | ▼ -6231.4% |
| 2011 | 0.00x | CN¥-261.74K | CN¥-6.49 Million | CN¥175.00 Million | ▼ -126.7% |
| 2010 | 0.01x | CN¥928.13K | CN¥-12.60 Million | CN¥165.66 Million | ▼ -97.8% |
| 2009 | 0.26x | CN¥36.33 Million | CN¥7.58 Million | CN¥140.53 Million | ▼ -12.1% |
| 2008 | 0.29x | CN¥37.88 Million | CN¥21.19 Million | CN¥128.78 Million | ▼ -70.6% |
| 2007 | 1.00x | CN¥131.36 Million | CN¥47.53 Million | CN¥131.16 Million | ▲ +67.7% |
| 2006 | 0.60x | CN¥69.29 Million | CN¥55.39 Million | CN¥116.04 Million | ▲ +297.6% |
| 2005 | 0.15x | CN¥20.02 Million | CN¥8.48 Million | CN¥133.32 Million | ▲ +62.0% |
| 2004 | 0.09x | CN¥9.78 Million | CN¥1.35 Million | CN¥105.49 Million | ▲ +131.1% |
| 2003 | -0.30x | CN¥-30.94 Million | CN¥-41.13 Million | CN¥103.88 Million | ▼ -190.3% |
| 2002 | 0.33x | CN¥39.70 Million | CN¥21.80 Million | CN¥120.32 Million | ▲ +166.0% |
| 2001 | 0.12x | CN¥19.49 Million | CN¥10.52 Million | CN¥157.11 Million | ▲ +262.4% |
| 2000 | 0.03x | CN¥5.29 Million | CN¥-9.67 Million | CN¥154.60 Million | ▼ -95.1% |
| 1999 | 0.70x | CN¥66.62 Million | CN¥49.09 Million | CN¥95.68 Million | ▲ +183.3% |
| 1998 | 0.25x | CN¥21.46 Million | CN¥2.36 Million | CN¥87.30 Million | — |